Medtronic plc DEFA14A, filed Oct 13, 2020

Medtronic plc (MDT)

DEFA14A 2020-10-13

Added on October 15, 2026


☐		Preliminary Proxy Statement

☐		CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (AS PERMITTED BY RULE 14a-6(e)(2))

☐		Definitive Proxy Statement

☒		Definitive Additional Materials

☐		Soliciting Material Pursuant to §240.14a-12



☒	No fee required.

☐	Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.

	(1)	Title of each class of securities to which transaction applies:
	(2)	Aggregate number of securities to which transaction applies:
	(3)	Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
	(4)	Proposed maximum aggregate value of transaction:
	(5)	Total fee paid:

☐	Fee paid previously with preliminary materials.

☐	Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

	(1)	Amount Previously Paid:
	(2)	Form, Schedule or Registration Statement No.:
	(3)	Filing Party:
	(4)	Date Filed:


		MEDTRONIC PLC		Meeting Information Meeting Type: Annual General Meeting For holders as of: October 15, 2020


				Date: December 11, 2020 Time: 9:00 AM U.S. Central Time
				(3:00 PM Irish Time)

				Location: Meeting live via the Internet-please visit
				www.virtualshareholdermeeting.com/MDT2020.
		MEDTRONIC PLC ATTN: MARCY CAMAROTTO 710 MEDTRONIC PARKWAY MS LC300 MINNEAPOLIS, MN 55432-5604		You are receiving this communication because you hold shares in the company named above. This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com, or scan the QR Barcode on the reverse side, or easily request a paper copy (see reverse side). We encourage you to access and review all of the important information contained in the proxy materials before voting.
				See the reverse side of this notice to obtain proxy materials and voting instructions.


		Proxy Materials Available to VIEW or RECEIVE:
		PROXY STATEMENT ANNUAL REPORT
		How to View Online:
		Have the information that is printed in the box marked by the arrow (located on the following page) and visit: www.proxyvote.com, or scan the QR Barcode below.
		How to Request and Receive a PAPER or E-MAIL Copy:
		If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:

		1) BY INTERNET:		www.proxyvote.com
		2) BY TELEPHONE:		1-800-579-1639
		3) BY E-MAIL*:		sendmaterial@proxyvote.com
		* If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the arrow (located on the following page) in the subject line.
		Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before November 29, 2020 to facilitate timely delivery.


The Board of Directors recommends you vote FOR the following proposals:
1.	To elect, by separate resolutions, the twelve director nominees named in the proxy statement to hold office until the 2021 Annual General Meeting of the Company.
	Nominees:
	1a.	Richard H. Anderson
	1b.	Craig Arnold
	1c.	Scott C. Donnelly
	1d.	Andrea J. Goldsmith, Ph.D.
	1e.	Randall J. Hogan, III
	1f.	Michael O. Leavitt
	1g.	James T. Lenehan
	1h.	Kevin E. Lofton
	1i.	Geoffrey S. Martha
	1j.	Elizabeth G. Nabel, M.D.
	1k.	Denise M. O’Leary
	1l.	Kendall J. Powell


		Vote By Internet: *Before The Meeting:* Go to www.proxyvote.com or from a smartphone, scan the QR Barcode above. Have the information that is printed in the box marked by the arrow (located on the following page) available and follow the instructions. *During The Meeting:* Go to www.virtualshareholdermeeting.com/MDT2020. Have the information that is printed in the box marked by the arrow (located on the following page) available and follow the instructions.
		Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.
		Vote By Phone: To vote by telephone, go to www.proxyvote.com to view the proxy materials and obtain the toll free number to call. Have the information that is printed in the box marked by the arrow (located on the following page) available and follow the instructions.


2.		To ratify, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Company’s independent auditor for fiscal year 2021 and to authorize, in a binding vote, the Board of Directors, acting through the Audit Committee, to set the auditor’s remuneration.

3.		To approve, in a non-binding advisory vote, named executive officer compensation (a “Say-on-Pay” vote).

4.		To renew the Board’s authority to issue shares.

5.		To renew the Board’s authority to opt out of pre-emption rights.

6.		Authorizing the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares.

7.		Transacting any other business that may properly come before the meeting.